Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients

This study is currently recruiting participants.

Verified December 2011 by Taipei Veterans General Hospital,Taiwan

Sponsor:

Information provided by (Responsible Party):

vghtpe user, Taipei Veterans General Hospital,Taiwan

ClinicalTrials.gov Identifier:

NCT01491295

First received: October 27, 2011

Last updated: November 2, 2012

Last verified: December 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2016
Estimated Primary Completion Date:	December 2016 (Final data collection date for primary outcome measure)